Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. 2007

Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
Leiden/Amsterdam Center for Drug Research, Division of Pharmacology, Leiden University, 2300 RA Leiden, The Netherlands. m.danhof@lacdr.leidenuniv.nl

Mechanism-based PK-PD models differ from conventional PK-PD models in that they contain specific expressions to characterize, in a quantitative manner, processes on the causal path between drug administration and effect. This includes target site distribution, target binding and activation, pharmacodynamic interactions, transduction, and homeostatic feedback mechanisms. As the final step, the effects on disease processes and disease progression are considered. Particularly through the incorporation of concepts from receptor theory and dynamical systems analysis, important progress has been made in the field of mechanism-based PK-PD modeling. This has yielded models with much-improved properties for extrapolation and prediction. These models constitute a theoretical basis for rational drug discovery and development.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010599 Pharmacokinetics Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology. ADME,ADME-Tox,ADMET,Absorption, Distribution, Metabolism, Elimination, and Toxicology,Absorption, Distribution, Metabolism, and Elimination,Drug Kinetics,Kinetics, Drug,LADMER,Liberation, Absorption, Distribution, Metabolism, Elimination, and Response
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug

Related Publications

Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
January 2009, Drug metabolism and pharmacokinetics,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
December 2007, Journal of pharmacokinetics and pharmacodynamics,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
September 2005, Pharmaceutical research,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
February 1993, Journal of clinical pharmacology,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
January 2023, Expert review of clinical pharmacology,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
January 2012, Methods in molecular biology (Clifton, N.J.),
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
October 1994, Clinical pharmacology and therapeutics,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
January 2003, The Journal of pharmacology and experimental therapeutics,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
January 2000, Archives of medical research,
Meindert Danhof, and Joost de Jongh, and Elizabeth C M De Lange, and Oscar Della Pasqua, and Bart A Ploeger, and Rob A Voskuyl
June 1981, Journal of pharmacokinetics and biopharmaceutics,
Copied contents to your clipboard!